Andrew Goodman > Goodwin > New York, United States > Lawyer Profile
Goodwin Offices
THE NEW YORK TIMES BUILDING
620 EIGHTH AVENUE
NEW YORK NY 10018
NEW YORK
United States
- Firm Profile
- Go to...
Andrew Goodman
Position
Partner
Career
Andrew Goodman is a partner in Goodwin’s Technology and Life Sciences groups, and a member of its Public M&A/Corporate Governance practice and Shareholder Activism & Takeover Defense practice. His practice focuses on public company mergers and acquisitions, friendly and hostile M&A, corporate governance, shareholder activism defense, and contested situations. He works with clients in a variety of industries, including technology and life sciences.
Education
JD, 2002, Tulane University Law School (cum laude) / BA, 1999, University of Rochester (cum laude)
Lawyer Rankings
United States > M&A/corporate and commercial > Shareholder activism
Goodwin has a history of representing clients under threat from some of the largest activism funds globally, and defending major public companies against takeover bids. The team is headed by Joseph Johnson and Andrew Goodman between the firm’s Boston and New York offices. The duo are well supported at associate level by Katherine Hand, who is a frequent advisor to public companies and their boards of directors on shareholder activism and takeover defense. Sean Donahue has left the firm.
Lawyer Rankings
Top Tier Firm Rankings
- Finance > Financial services regulation
- Industry focus > Cannabis
- Intellectual property > Patents: licensing
- Real estate > Real estate investment trusts (REITs)
- Media, technology and telecoms > Technology transactions
- M&A/corporate and commercial > Venture capital and emerging companies
Firm Rankings
- Finance > Capital markets: equity offerings
- Industry focus > Education
- Labor and employment > ERISA litigation
- Finance > Fintech
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: middle-market ($500m-999m)
- Investment fund formation and management > Mutual/registered/exchange-traded funds
- Dispute resolution > Securities litigation: defense
- Finance > Capital markets: debt offerings
- International Trade > CFIUS
- M&A/corporate and commercial > Corporate governance
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Dispute resolution > E-discovery
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Dispute resolution > Financial services litigation
- Antitrust > Merger control
- Intellectual property > Patents: litigation (full coverage)
- Investment fund formation and management > Private equity funds (including venture capital)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Real estate > Real estate
- M&A/corporate and commercial > Shareholder activism
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Tax > US taxes: non-contentious
- Labor and employment > Workplace and employment counseling
- Labor and employment > Employee benefits, executive compensation and retirement plans: design
- Dispute resolution > Leading trial lawyers
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Healthcare > Service providers
- International Trade > Customs, export controls and economic sanctions
- Dispute resolution > Leading trial lawyers
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)